Evolus, Inc. (EOLS): Price and Financial Metrics
Evolus, Inc. (EOLS)
Today's Latest Price: $3.66 USD
Updated Nov 24 4:00pm
Add EOLS to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 240 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
EOLS Stock Summary
- Of note is the ratio of Evolus Inc's sales and general administrative expense to its total operating expenses; 98.34% of US stocks have a lower such ratio.
- Revenue growth over the past 12 months for Evolus Inc comes in at 257.99%, a number that bests 97.38% of the US stocks we're tracking.
- Evolus Inc's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -84.3%, greater than the shareholder yield of just 4.59% of stocks in our set.
- Stocks that are quantitatively similar to EOLS, based on their financial statements, market capitalization, and price volatility, are YAYO, MGPI, RIBT, ESNT, and NWPX.
- Visit EOLS's SEC page to see the company's official filings. To visit the company's web site, go to www.evolus.com.
EOLS Stock Price Chart Interactive Chart >
EOLS Price/Volume Stats
| Current price | $3.66 | 52-week high | $14.64 |
| Prev. close | $3.74 | 52-week low | $2.85 |
| Day low | $3.54 | Volume | 445,900 |
| Day high | $3.75 | Avg. volume | 731,515 |
| 50-day MA | $3.74 | Dividend yield | N/A |
| 200-day MA | $4.49 | Market Cap | 123.52M |
Evolus, Inc. (EOLS) Company Bio
Evolus, Inc. provides medical aesthetic products for physicians and their patients in the United States. It offers DWP-450, an injectable 900 kilodalton botulinum toxin type A complex designed to address the needs of the facial aesthetics market. The company was founded in 2012 and is based in Irvine, California.
Loading social stream, please wait...